Business
GB Sciences Sponsors "Innovation in Medical Cannabis Therapies" Symposium
GB Sciences Sponsors "Innovation in Medical Cannabis Therapies" Symposium.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences Sponsors \"Innovation in Medical Cannabis Therapies\" Symposium\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences Sponsors \"Innovation in Medical Cannabis Therapies\" Symposium\nCanada NewsWire\nLAS VEGAS, March 15, 2018\n\n\n\nTop Minds Join GB Sciences' Think-Tank for the Advancement of Cannabis-based Medicines\n\n\n\nLAS VEGAS, March 15, 2018 /CNW/ -- GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce their sponsorship of the 1st Annual \"Innovation in Medical Cannabis Therapies\" Symposium in Las Vegas, Nevada, on Friday, June 1st, 2018.  Top innovators in cannabis tech, biotech, nanotech, and metabolomics are invited to this collaborative discussion, which was designed to explore the necessary advances across multiple fields that are required for the development of safe and effective plant-based medicines.\n\n\n \n \n\n \nThe GBS philosophy is that real innovation is only possible when researchers are supported to do the work that they love and are given the freedom to do it without the regimented business activities that characterize traditional pharma.  \n\n\"We predict an explosion of cannabis-based medicines in the next decade; however, there are still key areas where tech and biotech innovations are necessary before plant-based medicines will become a reality,\" explains Dr. Andrea Small Howard, Chief Science Officer of GB Sciences, Inc.  \"GB Sciences has developed an innovative research and development program by welcoming and collaborating with researchers who cannot otherwise find a suitable forum or research partner for their work due to their novel approaches in solving problems... in other words, people who think and operate just like us.\" \n\nThe GBS approach to research is always grounded in solid science and The Life Sciences team, a division of GB Sciences, has discovered that other researches who ascribe to this nontraditional mindset usually find funding and partnering difficult to come by. \n\n\"The uncomfortable truth is that traditional pharma has been dabbling in cannabinoid research for f...